Genomics Investment Syndicate III ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Genomics Investment Syndicate III ApS
Genomics Investment Syndicate III ApS (CVR number: 25589327) is a company from SKIVE. The company recorded a gross profit of -8.7 kDKK in 2023. The operating profit was -8.7 kDKK, while net earnings were -32.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.8 %, which can be considered poor and Return on Equity (ROE) was -11.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 24.8 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. Genomics Investment Syndicate III ApS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -5.93 | -6.13 | -5.66 | -7.38 | -8.70 |
EBIT | -5.93 | -6.13 | -5.66 | -7.38 | -8.70 |
Net earnings | - 241.72 | -99.55 | -28.06 | -31.12 | -32.28 |
Shareholders equity total | 462.31 | 362.76 | 334.70 | 303.58 | 271.30 |
Balance sheet total (assets) | 1 180.65 | 1 107.96 | 1 101.20 | 1 098.66 | 1 095.89 |
Net debt | -1 180.65 | -1 102.84 | -1 096.07 | -1 088.13 | -1 073.85 |
Profitability | |||||
EBIT-% | |||||
ROA | 16.2 % | 5.7 % | -0.5 % | -0.7 % | -0.8 % |
ROE | -41.4 % | -24.1 % | -8.0 % | -9.8 % | -11.2 % |
ROI | -37.9 % | -18.7 % | -1.6 % | -2.3 % | -2.9 % |
Economic value added (EVA) | 29.11 | 29.97 | 31.79 | 31.14 | 31.25 |
Solvency | |||||
Equity ratio | 39.2 % | 32.7 % | 30.4 % | 27.6 % | 24.8 % |
Gearing | 1.4 % | 1.5 % | 3.5 % | 8.1 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.6 | 1.5 | 1.4 | 1.4 | 1.3 |
Current ratio | 1.6 | 1.5 | 1.4 | 1.4 | 1.3 |
Cash and cash equivalents | 1 180.65 | 1 107.96 | 1 101.20 | 1 098.66 | 1 095.89 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BBB |
Variable visualization
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.